BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25427359)

  • 1. Epidemiology, clinical characteristics and treatment outcomes of healthcare- associated methicillin-resistant Staphylococcus aureus BLOODSTREAM infections at Chiang Mai University Hospital: a retrospective study.
    Chaiwarith R; Pacharasupal P; Sirisanthana T
    Southeast Asian J Trop Med Public Health; 2014 Jul; 45(4):897-905. PubMed ID: 25427359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USA300 methicillin-resistant Staphylococcus aureus emerging as a cause of bloodstream infections at military medical centers.
    Sherwood J; Park M; Robben P; Whitman T; Ellis MW
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):393-9. PubMed ID: 23466913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.
    Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and clinical characteristics of Staphylococcus aureus bloodstream infections in a tertiary-care center in Mexico City: 2003-2007.
    Ponce-de-León A; Camacho-Ortiz A; Macías AE; Landín-Larios C; Villanueva-Walbey C; Trinidad-Guerrero D; López-Jácome E; Galindo-Fraga A; Bobadilla-del-Valle M; Sifuentes-Osornio J
    Rev Invest Clin; 2010; 62(6):553-9. PubMed ID: 21416781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
    Jenkins TC; McCollister BD; Sharma R; McFann KK; Madinger NE; Barron M; Bessesen M; Price CS; Burman WJ
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):233-41. PubMed ID: 19199535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.
    Naves KS; Vaz da Trindade N; Gontijo Filho PP
    Rev Soc Bras Med Trop; 2012; 45(2):189-93. PubMed ID: 22534990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital.
    Gasch O; Ayats J; Ángeles Dominguez M; Tubau F; Liñares J; Peña C; Grau I; Pallarés R; Gudiol F; Ariza J; Pujol M
    Medicine (Baltimore); 2011 Sep; 90(5):319-327. PubMed ID: 21862935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital.
    Libert M; Elkholti M; Massaut J; Karmali R; Mascart G; Cherifi S
    J Hosp Infect; 2008 Jan; 68(1):17-24. PubMed ID: 17942190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.
    Wang JT; Wang JL; Fang CT; Chie WC; Lai MS; Lauderdale TL; Weng CM; Chang SC
    J Infect; 2010 Dec; 61(6):449-57. PubMed ID: 20875455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil.
    Riche CVW; Cassol R; Falci DR; Ramirez M; Dias CAG
    PLoS One; 2023; 18(4):e0283774. PubMed ID: 37053222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.